All Type of News
Government urged to promote domestic pharmaceutical firms' R&D efforts
Following the clinching of a free trade agreement (FTA) with the United States, major pharmaceutical firms in Korea have called for the government to work out measures to support their research and development project...
A world level of bio new drug R&D center in Daedeok Research Cluster.
The Korea Institute of Toxicology (KIT) and an American bio pharmaceutical company, ISIS, planned to establish "KIT-ISIS Bio New Drug R&D Center" in attendance of Daedeok Innopolice for a successful development of bio...
Pharmaceutical stocks to draw growing buy interest
Despite the prevailing view that Korean companies can no longer expect success only by depending on making generic drugs in an era of the Korea-U.S. FTA, pharmaceutical stocks of major drug makers will increase gains,...
SK Chemical and MSD Korea in strategic alliance for vaccines.SK Chemical announced on April 9 that the company made a strategic alliance with MSD Korea for the distribution of Gardasil, a first cervical cancer vaccine and Rotateq, an anti...
|
Diabetic patients can apply to Bayer Dream Fund until May 31
Bayer HealthCare said that until May 31, its 2007 Bayer Dream Fund will be open to anyone with diabetes or his/his family meeting the eligible criteria, who has a special dream that would not have been possible unless...
Political circles to check industrial damages by KORUS FTA.
The political circles have formed a special committee for a practical step to relieve any possible damages by the KORUS FTA in the vulnerable industries including pharmaceuticals.
The ruling Uri party held the 1st...
Rapid approval of generic drugs eyed
The Korea Food and Drug Administration announced on April 5 it has revised the rule concerning the screening of safety and efficacy of drugs, etc. as part of its effort to provide better support for the domestic drug ...
Disclosure of substandard drugs to be compulsory
A drug maker, importer or distributor will be required to immediately withdraw or undertake an appropriate withdrawal program against substandard drugs whenever they are found to be harmful.
The term substandard is...
Submission of bioequivalence test reports to be extended
The deadline for the bioequivalence test reports of about 250 drugs may be extended, as a number of pharmaceutical firms have failed to submit their test protocols because of a higher cost and tighter schedule, accord...
Consumer group calls for warning labels on cold remedies.
7 in 10 cold syrup remedies sold in pharmacies for infants and babies were detected with tar colorants, which essentially require for special medication advices at the pharmacy.
Korea Consumer Protection Board con...
